PubMedCrossRef 10. Enright MC, Day NP, Davies
CE, Peacock SJ, Spratt BG: Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J Clin Microbiol 2000,38(3):1008–1015.PubMed 11. Wichelhaus TA, Boddinghaus B, Besier S, Schafer V, Brade V, Ludwig A: Biological cost of this website rifampin resistance from the perspective of Staphylococcus aureus. Antimicrob Agents Chemother 2002,46(11):3381–3385.PubMedCrossRef 12. Didier JP, Villet R, Huggler E, Lew DP, Hooper DC, Kelley WL, Vaudaux P: Impact of ciprofloxacin exposure on Staphylococcus aureus genomic alterations linked with emergence of rifampin resistance. Antimicrob Agents Chemother 2011,55(5):1946–1952.PubMedCrossRef PD0332991 13. Chen R, Yan ZQ, Feng D, Luo YP, Wang LL, Shen DX: Nosocomial bloodstream infection in patients caused by Staphylococcus aureus: drug
susceptibility, outcome, and risk factors for hospital mortality. Chin Med J (Engl) 2012,125(2):226–229. 14. Li J, Weinstein AJ, Yang M: [Surveillance of bacterial resistance in China (1998–1999)]. Zhonghua Yi Xue Za Zhi 2001,81(1):8–16.PubMed 15. Campbell EA, Korzheva N, Mustaev A, Murakami K, Nair S, Goldfarb A, Darst SA: Structural mechanism for rifampicin inhibition of bacterial rna polymerase. Cell 2001,104(6):901–912.PubMedCrossRef 16. Jin DJ, Gross CA: Mapping and sequencing of mutations in the Escherichia coli rpoB gene that lead to rifampicin resistance. J Mol Biol 1988,202(1):45–58.PubMedCrossRef 17. Bolotin S, Alexander DC, Chedore P, Drews SJ, Jamieson F: Molecular characterization of drug-resistant Mycobacterium tuberculosis isolates from Ontario, Canada. www.selleckchem.com/products/bay-57-1293.html J Antimicrob Chemother 2009,64(2):263–266.PubMedCrossRef 18. Wichelhaus TA, Schafer V, Brade V, Boddinghaus B: Molecular characterization of rpoB mutations conferring cross-resistance to rifamycins on methicillin-resistant Staphylococcus
aureus. Antimicrob Agents Chemother 1999,43(11):2813–2816.PubMed 19. O’Neill AJ, Huovinen T, Fishwick CW, Chopra I: Molecular genetic and structural modeling studies of Staphylococcus aureus RNA polymerase and the fitness of rifampin resistance genotypes in relation to clinical prevalence. Antimicrob Agents Chemother Cytidine deaminase 2006,50(1):298–309.PubMedCrossRef 20. Frenay HM, Bunschoten AE, Schouls LM, van Leeuwen WJ, Vandenbroucke-Grauls CM, Verhoef J, Mooi FR: Molecular typing of methicillin-resistant Staphylococcus aureus on the basis of protein A gene polymorphism. Eur J Clin Microbiol Infect Dis 1996,15(1):60–64.PubMedCrossRef 21. Liu Y, Wang H, Du N, Shen E, Chen H, Niu J, Ye H, Chen M: Molecular evidence for spread of two major methicillin-resistant Staphylococcus aureus clones with a unique geographic distribution in Chinese hospitals. Antimicrob Agents Chemother 2009,53(2):512–518.PubMedCrossRef 22. Harris SR, Feil EJ, Holden MT, Quail MA, Nickerson EK, Chantratita N, Gardete S, Tavares A, Day N, Lindsay JA, et al.